Anti-proliferative, pro-apoptotic and anti-invasive effect of EC/EV system in human osteosarcoma

Francesca Punzo; Chiara Tortora; Daniela Di Pinto; Iolanda Manzo; Giulia Bellini; Fiorina Casale; Francesca Rossi

doi:10.18632/oncotarget.17089

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Anti-proliferative, pro-apoptotic and anti-invasive effect of EC/EV system in human osteosarcoma

Francesca Punzo, Chiara Tortora, Daniela Di Pinto, Iolanda Manzo, Giulia Bellini, Fiorina Casale and Francesca Rossi _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:54459-54471. https://doi.org/10.18632/oncotarget.17089

Metrics: PDF 1490 views | HTML 2963 views | ?

Abstract

Francesca Punzo1,2, Chiara Tortora1,2, Daniela Di Pinto1, Iolanda Manzo2, Giulia Bellini2, Fiorina Casale1 and Francesca Rossi1

1Department of Women, Child and General and Specialist Surgery, Second University of Naples, 80138 Naples, Italy

2Department of Experimental Medicine, Division of Pharmacology “Leonardo Donatelli”, The Second University of Naples, 80138 Naples, Italy

Correspondence to:

Francesca Rossi, email: [email protected]

Keywords: EC/EV system, osteosarcoma, OS cell lines, RTX, JWH-133

Received: December 23, 2016 Accepted: February 28, 2017 Published: April 13, 2017

ABSTRACT

Osteosarcoma is the most common and aggressive bone tumor in children. The Endocannabinoid/Endovanilloid system has been proposed as anticancer target in tumor of different origins. This system is composed of two receptors (CB1 and CB2), the Transient Potential Vanilloid 1 (TRPV1) channel and their ligands and enzymes. CB1 is expressed mainly in central nervous system while CB2 predominantly on immune and peripheral cells. We investigated the effects of JWH-133 (CB2 agonist) and RTX (TRPV1 agonist) in six human Osteosarcoma cell lines: MG-63, U-2OS, MNNG/HOS, Saos-2, KHOS/NP, Hs888Lu, by Apoptosis and Migration-Assay. We also compared the effects of these compounds on Caspase-3, AKT, MMP-2 and Notch-1 regulation by Q-PCR and Western Blotting.

We observed an anti-proliferative, pro-apoptotic, anti-invasive effect. Our results show that both CB2 stimulation and TRPV1 activation, in different Osteosarcoma cell lines, can act on the same pathways to obtain the same effect, indicating the Endocannabinoid/Endovanilloid system as a new therapeutic target in Osteosarcoma.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17089

Publication Alerts

Research Papers:

Anti-proliferative, pro-apoptotic and anti-invasive effect of EC/EV system in human osteosarcoma

Abstract